rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport
N/A
18 Years
65 Years
18 Years
65 Years
Not Enrolling
Both
Bone Healing, Bone Morphogenetic Proteins, Bone Transport
Both
Bone Healing, Bone Morphogenetic Proteins, Bone Transport
Trial Information
rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport
Inclusion Criteria:
- Patients treated with bone transport (Ilizarov technique) and have non-union of the
docking site, which is characterized by absence of bridging callus after two months
of compression in the docking site.
Exclusion Criteria:
- Allergy for inductos
- active growth,
- malignancy
- infection
- PAD
- pathological fracture
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Bone healing in the docking site
Outcome Time Frame:
up to 4 months
Safety Issue:
No
Authority:
Belgium: Federal Agency for Medicinal Products and Health Products
Study ID:
2012-005664-10
NCT ID:
NCT01756144
Start Date:
February 2013
Completion Date:
April 2015
Related Keywords:
- Bone Healing
- Bone Morphogenetic Proteins
- Bone Transport
Name | Location |
|---|
